WA Regulators Advance Plan to Help Cannabis Firms with Federal Registration

October 9, 2026

Photo by fr0ggy5 via Unsplash.

Three votes, zero dissent, and a petition that's been sitting on the Washington State Liquor and Cannabis Board's desk since mid-August finally got its green light on October 7, 2026. The Board voted 3-0 to accept a rulemaking petition from Caitlein Ryan and The Cannabis Alliance, agreeing to begin the formal process of creating what the industry is calling Medical Cannabis Verification Certificates -- documents that licensed retailers, producers, and processors could use to prove their regulatory status to federal agencies.

The timing isn't a coincidence. Attorney General Todd Blanche's April order moved state-licensed medical cannabis products from Schedule I to Schedule III, and the Trump administration followed with an executive order pushing for faster rescheduling action plus a new DEA portal for medical cannabis firms to register as recognized federal operators. Washington businesses now have a theoretical door into federal recognition -- but no standardized way to prove they belong in the room. That's the gap this petition tries to fill. It's worth being clear from the outset, though: accepting a petition is the opening move in a rulemaking process, not the arrival of a finished certification program.

What the Petition Actually Asks For

Photo by 2H Media via Unsplash.

The petition itself, filed August 13, 2026, is narrowly drafted but ambitious in what it's reaching for. Caitlein Ryan and The Cannabis Alliance asked the LCB to adopt a new rule under chapter 314-55 WAC that would direct the Board to issue Medical Cannabis Verification Certificates to any licensed retailer, producer, or processor that requests one. The certificates wouldn't grant new privileges or change what a business can sell -- they'd simply confirm, on paper, that the business participates in state-authorized medical cannabis activity under RCW 69.50 and RCW 69.51A, Washington's foundational cannabis and medical cannabis statutes.

What makes the request notable is the breadth of uses the petition lists for these certificates. It names governmental, regulatory, financial, research, insurance, litigation, and federal registration purposes as intended applications. That's a wide net, and it reflects how many different doors a Washington cannabis business might need to knock on now that federal agencies, banks, and insurers are all starting to ask the same basic question: can you prove you're operating a legitimate, state-sanctioned medical cannabis business? Right now, the honest answer for most Washington licensees is that no single document answers that cleanly, because the state's licensing system wasn't built with federal verification in mind.

Why This Matters Now: The Federal Rescheduling Backdrop

None of this is happening in a vacuum. In April, President Trump signed an executive order calling for immediate action on rescheduling cannabis products tied to state medical programs, and Attorney General Todd Blanche followed with an order moving marijuana products regulated under a state medical cannabis license -- along with any FDA-approved marijuana products -- from Schedule I to Schedule III of the Controlled Substances Act. That's a meaningful shift on paper, even if it stops well short of full legalization or descheduling.

The DEA followed up by standing up an online registration portal where qualifying medical cannabis firms can apply for recognition as legal cannabis operators under the new federal framework. That portal is the practical reason this petition landed when it did. A business can't register through a federal system if it has no documentation establishing that it actually operates under a state medical cannabis framework rather than purely recreational licensing. Washington's existing paperwork -- license certificates, tax records, standard LCB documentation -- wasn't designed to answer that specific question, which is exactly the hole Ryan and The Cannabis Alliance are trying to patch.

It's worth repeating that federal rescheduling status, DEA registration requirements, and what qualifies as a state medical cannabis license vary quite a bit depending on where you're located, and the rules are actively moving. Anyone trying to use this process should confirm the current federal and state requirements rather than assume Washington's approach will look identical to another state's.

The Board's Unanimous Vote -- and Staff's Objections

Photo by A G via Pexels.

The 3-0 vote -- Chair Jim Vollendroff joined by members Ollie Garrett and Pete Holmes -- came despite a staff recommendation to deny the petition outright. LCB staff laid out a fairly detailed set of objections before the Board overruled them, and those objections are worth understanding because they'll likely shape whatever rule eventually emerges.

Staff warned that because the Board and the Department of Health don't maintain comprehensive records distinguishing medical activity from recreational activity at the individual licensee level, any verification program would probably have to lean on licensee self-reporting to fill the gaps. That raises an obvious question about reliability -- self-reported data is only as good as the incentive structure behind it, and staff flagged real concerns about verifying claims without a documentation system already built for that purpose.

Staff also pointed to the administrative burden such a program would create, cautioning that reviewing and issuing certificates, verifying self-reported claims, and managing renewals could strain an agency that wasn't budgeted or staffed for this function. There was also a structural argument: Washington's legislature designed a combined three-tier system serving both recreational and medical markets together, not separate medical-only licenses, and staff argued that issuing certificates implying a distinct medical track could run against that legislative intent. Since the certificates wouldn't restrict a licensee from also selling recreational product, staff doubted they'd satisfy whatever standard federal agencies ultimately apply to real medical cannabis operators.

Washington's Integrated System Is the Real Complication

Photo by BiW_HORiZON via Pixabay.

The staff objections point to something genuinely tricky about Washington's cannabis market: it doesn't separate medical and recreational activity the way states like Oklahoma or Arkansas do with standalone medical-only licenses. A Washington retailer can sell to medical patients and recreational customers out of the same storefront, under the same license, often from the same inventory. That integration has real benefits for patients and businesses alike, but it makes it structurally difficult to produce a clean, federally credible statement that says this specific license is medical cannabis activity, full stop.

Board member Pete Holmes didn't dispute the staff's concerns during the discussion, but he framed the vote as part of a broader posture the Board wants to take toward federal rescheduling -- cooperative rather than reflexively cautious. His comments suggested the Board sees value in signaling willingness to work with federal agencies even while acknowledging the mechanics aren't fully worked out. At the same time, Holmes cautioned against letting businesses believe that any state action right now can fully resolve what he described as the precarious position the industry still occupies, caught between a shifting federal posture and a state regulatory structure that predates this rescheduling moment entirely.

One thing worth noting for licensees watching this closely: the petition as accepted wouldn't create a new license category, add an endorsement to existing licenses, or require the Board to bring on additional staff. It's conceived as a documentation mechanism layered on top of the existing licensing structure, not a parallel certification track.

What Happens Next

Photo via Pexels.

Accepting a rulemaking petition is a specific procedural step under Washington's Administrative Procedure Act, and it's an early one. The Board has now committed to moving forward, but it still has to work out the details that will determine whether this program is actually useful: what documentation would qualify a licensee for a certificate, how self-reported claims get verified against existing records, how often certificates would need renewal, and what format they'd take to be recognized by federal agencies reviewing DEA portal applications.

No timeline has been set for draft rule language, and there's no scheduled public comment period yet -- those steps come later in the rulemaking process and will likely generate significant input from licensees, trade groups, and possibly federal stakeholders watching how states handle this. Given that Washington isn't the only state running an integrated medical-recreational system, other state cannabis regulators are likely to watch how this plays out as a test case for handling federal verification demands without a dedicated medical license structure.

Businesses that want to use the federal DEA registration portal now, before Washington finalizes anything, should keep an eye on LCB rulemaking notices and talk to legal counsel about what documentation might currently satisfy federal requirements in the interim. Relying on a certificate program that's still months or years from implementation isn't a workable strategy for anyone facing a registration deadline today.

The unanimous vote says less about the certificates themselves and more about where Washington regulators want to stand as federal rescheduling unfolds. Overruling staff's recommendation wasn't a small thing -- it tells you the Board wanted to be seen moving toward cooperation with federal agencies even while its own technical experts flagged real legal and logistical holes in the plan. That's a political signal as much as a regulatory one.

Whether a Medical Cannabis Verification Certificate will actually help a Washington business get recognized through the DEA's portal is still an open question, and it'll stay open until rulemaking produces concrete criteria that federal agencies are willing to accept. A document that says a licensee participates in state-authorized medical cannabis activity only matters if the party reading it -- a bank, an insurer, a federal registrar -- agrees that it means something.

For now, businesses should treat this vote as what it is: the start of a conversation Washington regulators are willing to have, not a pathway they've finished building. Anyone counting on fast federal recognition off the back of this petition should watch the rulemaking docket closely and keep expectations tied to what's actually been finalized, not what's merely been proposed.